Health Condition 1: null- Neonatal Sepsis
Conditions
Interventions
Control Intervention1: not applicable since this is an observational study.
: not applicable since this is an observational study.
Sponsors
BECTION DICKINSON AND COMPANY
Eligibility
Inclusion criteria
Inclusion criteria: Term or Pre-term neonates (born at greater than 28 weeks gestation) admitted to neonatal intensive care units, presenting with signs and symptoms suggestive of systemic infection and requiring a full sepsis evaluation and antibiotic treatment will be eligible for inclusion in the study irrespective of their birth weight and postnatal age.
Exclusion criteria
Exclusion criteria: Patients who were already receiving parenteral antibiotics at time of initial sepsis evaluation will be excluded
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Utility of these immunological markers(CD11b,CD64,CD88,CD282) for diagnosis of Neonatal sepsis.Timepoint: 3 months for data acquisition and 3 months for data analysis | — |
Secondary
| Measure | Time frame |
|---|---|
| Eventually establishing arapid,sensitive,simple & cost effective method for diagnosis of Neonatal sepsisTimepoint: 6 months | — |
Countries
India
Contacts
Public ContactDr Manisha Madkaikar
National Institute of Immunohaematology
Outcome results
None listed